Shephard Mpofu
Direttore Tecnico/Scientifico/R&S presso ACELYRIN, INC.
Profilo
Shephard Mpofu is currently working as the Chief Medical Officer at ACELYRIN, Inc. since 2024.
Previously, he worked at Novartis Gene Therapies, Inc. as the Chief Medical Officer & Senior Vice President.
Dr. Mpofu completed his undergraduate degree at the University of Zimbabwe.
Posizioni attive di Shephard Mpofu
| Società | Posizione | Inizio |
|---|---|---|
| ACELYRIN, INC. | Direttore Tecnico/Scientifico/R&S | 09/05/2024 |
Precedenti posizioni note di Shephard Mpofu
| Società | Posizione | Fine |
|---|---|---|
| AVEXIS INC | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Shephard Mpofu
| University of Zimbabwe | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ACELYRIN, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Borsa valori
- Insiders
- Shephard Mpofu